FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmacology and medicine. The group of inventions involves pharmaceutical compositions containing 5-azacytidine for the oral introduction wherein the compositions release a cytidine analogue substantially in stomach, a method of treating an individual suffering a disease associated with abnormal cell proliferation which involves the oral introduction of the pharmaceutical composition into the individual, using 5-azacytidine for preparing the pharmaceutical composition for treating the disease associated with abnormal cell proliferation.
EFFECT: invention provides higher clinical effectiveness.
9 tbl, 9 ex, 23 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL COMPOUNDS CONTAINING CYTIDINE ANALOGUES AND METHODS FOR USE THEREOF | 2018 |
|
RU2765076C2 |
| SOLID DISPERSIONS CONTAINING APOPTOSIS PROMOTING PROTEINS | 2010 |
|
RU2550134C2 |
| METHODS FOR ADMINISTRATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOLE-2-YL)PIPERIDINE-2,6-DIONE IN CERTAIN TYPES OF LEUKEMIA | 2006 |
|
RU2406501C2 |
| LYOPHILIZED PHARMACEUTICAL COMPOSITIONS | 2016 |
|
RU2723590C2 |
| DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION | 2011 |
|
RU2609833C2 |
| METHOD FOR PRODUCING FUNCTIONAL PROTEIN FROM DNA HAVING NONSENSE MUTATIONS, AND TREATING ASSOCIATED DISORDERS | 2007 |
|
RU2462246C2 |
| CYSTEAMINE DIOXYGENASE-RESISTANT ANALOGUES OF CYSTEAMINE AND THEIR USE | 2016 |
|
RU2766579C2 |
| COMBINATION OF OZOGAMICIN INOTUZUMAB AND TORIZEL FOR TREATING CANCER | 2012 |
|
RU2607594C2 |
| COMPOSITION CONTAINING AN ALGAL PROTEOGLYCAN EXTRACT, AND USE THEREOF | 2017 |
|
RU2739558C2 |
| METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH LSD1, LSD1 INHIBITORS | 2020 |
|
RU2826217C1 |
